DEPOTSYSTEM ENTHALTEND GLATIRAMERAZETAT

European patent · EP3536333 · In force

Register entry

Publication number
EP3536333
Application number
EP18205308
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 19, 2010
Published
Sep 11, 2019
Granted
Aug 3, 2022
Protection ends at the latest
Aug 18, 2030
Next annual fee due
Aug 31, 2026
IPC classes
A61K 38/16 (2006.01)
A61P 25/28 (2006.01)
A61P 37/02 (2006.01)
A61K 9/19 (2006.01)
A61K 9/70 (2006.01)
A61K 38/02 (2006.01)
Priority
US 29192810 P 04.01.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. Jun 14, 2023

    Change

    Published in Swissreg on 14.06.2023

  5. Oct 25, 2022

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 25.10.2022

  6. Sep 29, 2022

    Change

    Published in Swissreg on 29.09.2022

  7. Aug 3, 2022

    Granted

    Published in Swissreg on 03.08.2022

Parties

Holder

Mapi Pharma Limited

16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, IL

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

RUBNOV, Shai

6581141 Tel Aviv, IL

MAROM, Ehud

6107079 Tel Aviv, IL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.